|Last Updated: September 25, 2022 @ 9:13 am|
|Stability:||Ambient: 1 Month(s); Refrigerated: 1 Month(s); Frozen: 12 Month(s); Incubated: Unacceptable|
|Interpretive Data:||Please see report for interpretive data.|
The Aptima Combo 2 Assay is a qualitative nucleic acid amplification test (NAAT) for the detection of Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (GC). The analytic performance characteristics have been determined by Interpath Laboratory for sources not FDA approved. Results depend on sufficient levels of DNA to be detected, absence of inhibitors and adequate sample collection. Results should be interpreted in conjunction with clinical findings and should not preclude additional studies if findings do not correlate.
It is preferable to locate tests on the website and not rely on printed test information, which may soon be out of date.
Updated test information can only be guaranteed by using this website.